Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Eur Heart J. 2020 Jun 21;41(24):2313-2330.
doi: 10.1093/eurheartj/ehz962.
1 Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden.
2 Endocrinology-Metabolism Division, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France.
3 National Institute for Health and Medical Research (INSERM), Paris, France.
4 Department of Atherosclerosis Research, Children's Hospital Oakland Research Institute and UCSF, Oakland, CA 94609, USA.
5 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
6 Department of Clinical Medicine, Heart Diseases, Aarhus University, Aarhus, Denmark.
7 Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain.
8 Department of Laboratory Medicine, Medical University of Vienna, Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
9 Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.
10 Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.
11 Department of Physiology, University of California, Los Angeles, Los Angeles, CA, USA.
12 Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA, USA.
13 Department of Medicine, Robarts Research Institute, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
14 Monash Cardiovascular Research Centre, Monash University, Melbourne, Australia.
15 Department of Clinical Biochemistry, The Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Denmark.
16 School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Australia.
17 Department of Cardiology, Lipid Disorders Clinic, Royal Perth Hospital, Perth, Australia.
18 INSERM UMRS1166, Department of Endocrinology-Metabolism, ICAN - Institute of CardioMetabolism and Nutrition, AP-HP, Hopital de la Pitie, Paris, France.
19 Departments of Medicine, Physiology and Pharmacology, Knight Cardiovascular Institute, Center of Preventive Cardiology, Oregon Health & Science University, Portland, OR, USA.
20 Centre for Naturally Randomized Trials, University of Cambridge, Cambridge, UK.
21 Institute for Advanced Studies, University of Bristol, Bristol, UK.
22 MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
23 Trinity College Dublin, Dublin, Ireland.
24 Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
25 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
26 Department of Cardiology, Charité - University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin, Germany.
27 Berlin Institute of Health (BIH), Berlin, Germany.
28 Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig, Liebigstraße 20, Leipzig, Germany.
29 Research Unit of Lipids and Atherosclerosis, IISPV, CIBERDEM, University Rovira i Virgili, C. Sant Llorenç 21, Reus 43201, Spain.
30 Laboratory of Clinical Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands.
31 Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
32 Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College London, London, UK.
33 Deutsches Herzzentrum München, Klinik für Herz- und Kreislauferkrankungen, Faculty of Medicine, Technische Universität München, Lazarettstr, Munich, Germany.
34 DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
35 Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
36 Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
37 Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
38 Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, and IRCCS MultiMedica, Milan, Italy.
39 Department of Medicine, Irving Institute for Clinical and Translational Research, Columbia University, New York, NY, USA.